We are actively working on helping people who suffered financial loss or injuries from the following products or drugs listed below.
Sony, Phillips, or Toshisha Products
Yaz, Yasmin or Ocella
SONY, PHILLIPS OR TOSHIBA PRODUCTS
If you have purchased a Blue Ray DVD product directly from these manufacturers, on-line or from one of their stores, then you as a directurchaser, have a claim and could be entitled to compensation.
If you purchased any one of these products as an indirect purchaser, say from Best Buy or Circuit City or a similar store, you may also have a claim.
The U.S. Food and Drug Administration (FDA) recently asked manufacturers of all Gadolinium-based contrast agents to include a new boxed warning on the product label. These contrast agents are used to enhance the quality of magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA). In patients with depressed kidney function (which is often unknown) exposure to Gadolinium places the patient at significant risk for developing a potentially fatal disease known as Nephrogenic Systemic Fibrosis (NSF) or Nephrogenic Fibrosing Dermopathy (NFD). People who develop NSF or NFD may experience a thickening of the skin and other organs, which can limit their ability to move, extend joints, and can lead to significant pain and even death. Other problems may include dark patches on the skin that appear rough and hard with raised plaques or papules, which may appear as elevations of the skin. Joint and bone pain, as well as swelling of the feet and hands, have also been reported. The FDA first warned about NSF and NFD associated with Gadolinium in June of 2006 and again in December of 2006. As of April of 2007, the FDA had received a considerable number of additional cases involving these conditions.
We are currently evaluating cases in which patients developed NSF or NFD after being exposed to any of these Gadolinium-based contrast agents: Magnevist, MultiHance, Omniscan, Optimark, and ProHanse. Exposure to these agents is the only known cause of NSF and NFD.
YAZ, YASMIN or OCELLA
Yaz is a combination birth control pill containing drospirenone and ethinyl estradiol. It is marketed not only as a contaceptive pill, but as a proven treatment for prementrual dysphoric disorder (PMDD), a condition with server emotional and physical premenstrual symptoms. Yaz is also marketed as an effective treatment for moderate acne. However, studies indicate that Yaz poses a particular health hazard because one of its two primary ingredients, drospirenone, is a diuretic, which can cause an increase in potassium levels in the bloodand lead to hyperkalemia, which causes heart rhythm disturbances that can cause blood clots leading to sudden cardiac deathor pulmonary embolism or strokes. Diuretics can also cause significant problems with the gallbladder, leading to gallbladder removal.
If you have taken Yaz, Yasmin or Ocella and experience any of these problems, please contact us.
Paxil® (paroxetine) is an anti-depressant manufactured by GlaxoSmithKline. Recently Public Health Advisories have been issued for Paxil® regarding an increased risk of heart birth defects, persistent pulmonary hypertension (PPHN), omphalocele (an abnormality in newborns in which the infant’s intestine or other abdominal organs protrude from the navel) or craniosynostosis (connections between sutures-skull bones, prematurely close during the first year of life, which causes an abnormally shaped skull) in children born to mothers exposed to Paxil®.
If you took this drug before you became pregnant or during your pregnancy, you may have a claim for a child born with a birth defect.
Gardasil, a vaccine manufactured and marked by Merck and Company, is marketed as a preventative for cervical cancer. However, Gardasil has not been proven to prevent cervical cancer. In fact, it is a vaccine to prevent only four types of the sexually transmitted disease HPV (human papillomavirus) two of which are associated with cervical cancer. These two types of HPV are present in only 3.3% of the cases. Scientific data indicates that the vaccine may not last longer than five years, if that long. The druge is indicated for young women an dmean from the age of nine years old up to 26 years old, though the vaccine is primarily given to girls. The Vaccine Adverse Event Reporting System has received over 16,000 reports of adverse events related to teh administration of this vaccine including 50 deaths. Serious adverse events include Guillian Barre, lupus, seizures, paralysis, blood clots, brain inflammation and death. The vaccine is recommended to most young girls in their earlier teens. Some believe this drug could be the next Vioxx due to the dangers involved.
If you or one of your children have had this vaccine and experience problems, contact us.
WE ARE SIGNING UP CLIENTS NOW!